In the Phase 3 REZILIENT3 study, zipalertinib combination therapy demonstrated longest median progression-free survival observed to date in first-line EGFR exon20ins NSCLC  After agreement with the U.S. FDA, Real-Time Oncology Review program submission process initiated; completion of NDA submission expected by year-end 2026 CAMBRIDGE, Mass., Oct. 01, 2026 (GLOBE NEWSWIRE) — Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, disease-modifying T cell engagers in autoimmune diseases and cancer, today announced the initiation of a New Drug Application (NDA) submission to the U.S. Food and Drug Administration (FDA) for zipalertinib in combination with platinum-based chemotherapy for the treatment of patients with previously untreated, locally advanced...

TORONTO and HOUSTON, Oct. 01, 2026 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company developing Superkines for targeting cancer and autoimmune diseases, today announced the voting results from the Company’s annual general and special meeting of shareholders held today, October 1, 2026 (the “Meeting”). Medicenna is pleased to announce that all of the nominees listed in its management information circular dated August 19, 2026 (the “Circular”), were elected as directors. Each director was elected with greater than 97% of the votes cast for by shareholders present at the Meeting or represented by proxy. The results of the vote are detailed below:Nominee Votes For % of Votes For Votes Against % of Votes AgainstMr. Albert Beraldo 27,751,517 97.42% 736,191 2.58%Mr....

TORONTO, Oct. 01, 2026 (GLOBE NEWSWIRE) — Carbon Streaming Corporation (Cboe CA: NETZ) (OTCID: OFSTF) (FSE: M2Q) (“Carbon Streaming” or the “Company”) has entered into an agreement with Community Carbon and UpEnergy Group (collectively, the “UPE Parties”) pursuant to which the Company will receive total consideration of US$6.0 million in connection with the termination of the Community Carbon Stream and transfer of the Company’s remaining portfolio of carbon credits, with a portion of the consideration funded through the sale of certain CORSIA-tagged Tanzanian cookstove carbon credits to a third-party purchaser. The US$6.0 million total consideration is composed of the following: (i) US$2.35 million of proceeds from the Company’s sale of certain CORSIA-tagged Tanzanian cookstove carbon credits to a third-party purchaser; (ii) US$1.47...

HOUSTON, Oct. 01, 2026 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of September 30, 2026. As of September 30, 2026, the Company’s net assets were $2.6 billion, and its net asset value per share was $15.42. As of September 30, 2026, the Company’s asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 589% and the Company’s asset coverage ratio under the 1940 Act with respect to total leverage (debt and preferred stock) was 471%.STATEMENT OF ASSETS AND LIABILITIESSEPTEMBER 30, 2026   // (UNAUDITED)     (in millions)Investments   $ 3,694.3  Cash...

Expansion Recognizes the Strength of PECO’s Operating Platform while Generating Capital for PECO to Acquire Properties with Strong Growth Profiles CINCINNATI , Oct. 01, 2026 (GLOBE NEWSWIRE) — Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO”), one of the nation’s largest owners and operators of high-quality, grocery-anchored neighborhood shopping centers, today announced an amended and restated joint venture partnership with Northwestern Mutual, one of the largest commercial real estate mortgage and equity investors in the U.S., which extends the term of the venture, Grocery Retail Partners I LLC (“GRP I”), by 10 years to 2036. The expanded joint venture will acquire 13 high-quality, grocery-anchored shopping centers currently owned and operated by PECO across eight states. The portfolio is valued at approximately $377.5...

Expanded agreement with an existing AI infrastructure customer and new customer agreement increases contracted deployment pipeline and is expected to drive Company annualized revenue run rate to $1 billion by calendar Q3 2027 ChronoScale completes previously disclosed sale of Ekso Bionics business unitMENLO PARK, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) — ChronoScale Holdings Corporation (NASDAQ: CHRN) (“ChronoScale” or the “Company”), an accelerated compute platform purpose-built to support demanding artificial intelligence (AI) workloads, today announced a significant expansion of an existing customer agreement and a separate agreement with a new customer, that increases the scale of its contracted AI infrastructure deployments and further strengthens the Company’s contracted revenues. New Infrastructure Agreements ChronoScale...